Literature DB >> 12062604

Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?

Frank M Waterman1, Adam P Dicker.   

Abstract

PURPOSE: To determine the effect of edema on the dosimetric parameters V(100) (percentage of prostate volume that received a dose equal to or greater than the prescribed dose) and D(90) (minimal dose delivered to 90% of prostate volume) in 125I prostate brachytherapy and to determine whether the edema can be used to predict implant quality on the day of the implant (Day 0). METHODS AND MATERIALS: Fifty consecutive patients treated with (125)I implants who had two postimplant CT scans were selected for this study. The mean interval between the studies was 46 +/- 23 days. The implants were preplanned to deliver 150 Gy to the prostate plus a 3-5-mm symmetric dose margin using peripherally loaded 0.4-0.6-mCi (NIST-99) (125)I seeds. A dose-volume histogram was compiled for each postimplant CT scan. The V(100) and D(90) from the first and second CT scans were compared to determine the effect of edema on these parameters. A multivariate regression analysis was performed to define the linear relationships for predicting the V(100) or D(90) at 30-60 days after implant from the magnitude of the edema and the values of V(100) and D(90) on Day 0.
RESULTS: V(100) and D(90) increased by 5% +/- 6% and 15% +/- 17%, respectively, during the interval between the first and second postimplant CT scans. The mean edema was 1.53 +/- 0.20. The increases in V(100) and D(90) were found to be proportional to the edema and the values of V(100) and D(90) on Day 0. The increase in V(100) was also found to depend on the width of the preplan dose margin. Linear relationships were derived that predict the V(100) and D(90) at 30-60 days after implant with a standard error of +/-4% and +/-24 Gy, respectively.
CONCLUSION: V(100) and D(90) increased by 5% +/- 6% and 15% +/- 17%, respectively, during the first 30-60 days after implant. The results of a multivariate linear regression analysis showed that the increases in V(100) and D(90) were proportional to both the magnitude of the edema and the values of these parameters on Day 0. The relationships derived by linear regression analysis predict V(100) and D(90) at 30-60 days after implant to within +/-4% and +/-24 Gy, respectively. However, predicting the 30-60-day V(100) and D(90) on Day 0 is a poor substitute for obtaining a 30-60-day CT scan, because the uncertainty in the predicted values is greater by a factor of > or =2. Nevertheless, on average, the predicted values should provide a more reliable estimate of the actual V(100) and D(90) than the Day 0 values that ignore the effect of edema altogether. The increase in V(100) was also found to depend on the width of the preplan dose margin; therefore, our results for V(100) are only valid for implants planned with a 3-5-mm margin.

Entities:  

Mesh:

Year:  2002        PMID: 12062604     DOI: 10.1016/s0360-3016(02)02751-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Acute urinary morbidity following I-125 prostate brachytherapy.

Authors:  Toshio Ohashi; Atsunori Yorozu; Kazuhito Toya; Shiro Saito; Tetsuo Momma
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

2.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.

Authors:  T Shaikh; N G Zaorsky; K Ruth; D Y Chen; R E Greenberg; J Li; K Crawford; E M Horwitz
Journal:  Brachytherapy       Date:  2014-11-07       Impact factor: 2.362

4.  A simple technique for the generation of institution-specific nomograms for permanent prostate cancer brachytherapy.

Authors:  Kyle J Lafata; Harry Bushe; Jesse N Aronowitz
Journal:  J Contemp Brachytherapy       Date:  2014-09-23

5.  Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning.

Authors:  Laura Doyle; Adam J Hesney; Katherine L Chapman; Haisong Liu; Perry R Weiner; Adam P Dicker; Yan Yu; Timothy N Showalter
Journal:  J Contemp Brachytherapy       Date:  2012-09-29

6.  Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation.

Authors:  Deepti Patel; Alex Tan; Amy Brown; Tilley Pain
Journal:  J Med Radiat Sci       Date:  2020-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.